Yüklüyor......
Biosimilars as a Future, Promising Solution for Financial Toxicity: A Review with Emphasis on Bevacizumab
A biosimilar is a biochemical product like another already approved biologic agent, known as the reference agent. To be endorsed by the Food and Drug Administration (FDA), biosimilars must demonstrate that they are as safe and effective as their reference item, with no clinical distinction. Humanize...
Kaydedildi:
| Yayımlandı: | Cureus |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cureus
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7437115/ https://ncbi.nlm.nih.gov/pubmed/32832297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9300 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|